On Thursday, June 25, an expert panel of dermatologists, surgeons, and oncologists from Penn Medicine discussed the improved protocols to manage melanoma patients at Penn Medicine and in the community during the COVID-19 era. Christopher J. Miller, MD, Roman Bronfenbrener, MD, Dermatology, Emily Chu, MD, PhD, Dermatology, Giorgos Karakousis, MD, Endocrine and Oncologic Surgery, Lynn Schuchter, MD, Medical Oncology, and Joseph Sobanko, MD, Dermatology elaborate on screening, safety during treatment, and technology to enhance melanoma care.
Related Links:
Penn Medicine Abraham Cancer Center
Twitter @PennMDForum
Published
June 25, 2020
Created by
